发明名称 |
Methods for treating parkinson's disease by optically stimulating target cells |
摘要 |
Methods, systems and devices are implemented in connection with light-responsive ion channel molecules. One such method is implemented using a light-activated ion channel molecule that responds to a light stimulus. The method includes engineering the light-activated ion channel molecule in a cell; and activating the ion channel molecule, in response to light stimulus that is provided to the ion channel molecule and that has properties that do not activate a ChR2 ion channel, to allow ions to pass through the light-activated ion channel molecule. |
申请公布号 |
US9394347(B2) |
申请公布日期 |
2016.07.19 |
申请号 |
US201514694845 |
申请日期 |
2015.04.23 |
申请人 |
The Board of Trustees of the Leland Stanford Junior University |
发明人 |
Deisseroth Karl;Zhang Feng;Gradinaru Viviana |
分类号 |
C07K14/405;C07K14/47;C12N15/75;C12N15/85;C12N15/86;C12N7/00;A61N5/06;A61K41/00;A61K48/00;A61K31/713;C12N15/79;A61N5/067 |
主分类号 |
C07K14/405 |
代理机构 |
Bozicevic, Field & Francis LLP |
代理人 |
Bozicevic, Field & Francis LLP ;Borden Paula A. |
主权项 |
1. A method for treating Parkinson's Disease in an individual, the method comprising:
a) implanting into the individual a device comprising:
i) a recombinant expression vector comprising a nucleotide sequence encoding a Volvox carteri light-activated ion channel (VChR1) protein to provide localized depolarization of afferent axons of the subthalamic nucleus (STN); andii) a light-delivery mechanism,wherein the VChR1 protein is produced in the afferent axons; and b) activating the VChR1 protein with the light-delivery mechanism, thereby depolarizing the afferent axons and treating the disease. |
地址 |
Stanford CA US |